alexa Robert Veerhuis | OMICS International
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
View More»
 

Robert Veerhuis

Senior Reseracher at VU University Medical Center, Netherlands

Biography

Robert Veerhuis heads a neuroinflammation research group at the departments of Clinical Chemistry, Psychiatry, Pathology and Alzheimer center of the VU University medical center (VUmc). His PhD study at Leiden University was devoted to the role of the complement system in the clearance of immune complexes in autoimmune diseases. After a period in veterinary research, he started studying the neuroimmunological aspects of Alzheimer’s disease and related neurodegenerative diseases at the VUmc. He is an expert in the role of glial cells in the pathogenesis of AD and related disorders, and studies neuroinflammatory and glial cell changes in post mortem human brain tissue and adult human glial cell cultures. Using these model systems he participated in EU-funded projects on glial cells in prion disease and selection and testing potential therapeutic compounds for prion diseases in biochemical assays and human cell culture models. Recent pathogenesis-related work focuses on the role of microglia and astrocytes in the clearance of misfolded proteins, especially different aggregation forms of Abeta and the effects of amyloid associated factors hereon. Another line of research concerns identifying biomarkers (with focus on amyloid associated factors including complement factors and apolipoproteins in CSF and plasma) for early diagnosis and monitoring drug treatment of neurodegenerative diseases.

Research Interest

Clinical Chemistry, Psychiatry, Pathology, Alzheime, veterinary research, Neuroimmunological Disorders

Publications

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7